Fig. 3
From: Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent
Pharmacokinetic data following 29 administration by multiple routes. Plasma concentrations by IV, PO, and IP routes (A) and comparative plasma and brain concentrations following IP dosing (B)